These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28176847)

  • 21. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. O-linked-N-acetylglucosamine transferase is associated with metastatic spread of human papillomavirus E6 and E7 oncoproteins to the lungs of mice.
    Kim SH; Kim YS; Choi MY; Kim M; Yang JH; Park HO; Jang IS; Moon SH; Kim HO; Song DH; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi JY; Choi WS
    Biochem Biophys Res Commun; 2017 Feb; 483(2):793-802. PubMed ID: 27845045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.
    Rajasekaran N; Jung HS; Bae SH; Chelakkot C; Hong S; Choi JS; Yim DS; Oh YK; Choi YL; Shin YK
    Neoplasia; 2017 Oct; 19(10):735-749. PubMed ID: 28843398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
    Tang X; Zhang Q; Nishitani J; Brown J; Shi S; Le AD
    Clin Cancer Res; 2007 May; 13(9):2568-76. PubMed ID: 17473185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
    Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
    Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression.
    Poljak-Blazi M; Jaganjac M; Sabol I; Mihaljevic B; Matovina M; Grce M
    Toxicol In Vitro; 2011 Feb; 25(1):160-6. PubMed ID: 21044880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses.
    Kuner R; Vogt M; Sultmann H; Buness A; Dymalla S; Bulkescher J; Fellmann M; Butz K; Poustka A; Hoppe-Seyler F
    J Mol Med (Berl); 2007 Nov; 85(11):1253-62. PubMed ID: 17589817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Wang H; Gao P; Zheng J
    Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells.
    Jin H; Lee K; Kim YH; Oh HK; Maeng YI; Kim TH; Suh DS; Bae J
    Oncogene; 2016 Sep; 35(39):5106-18. PubMed ID: 26973248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
    Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
    J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel action modality of the diterpenoid anisomelic acid causes depletion of E6 and E7 viral oncoproteins in HPV-transformed cervical carcinoma cells.
    Paul P; Rajendran SK; Peuhu E; Alshatwi AA; Akbarsha MA; Hietanen S; Eriksson JE
    Biochem Pharmacol; 2014 May; 89(2):171-84. PubMed ID: 24565908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
    Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
    Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.